Suppr超能文献

无创性肝纤维化指标作为 2 型糖尿病微血管和大血管并发症的预测指标。

Noninvasive Liver Fibrosis Indices as Indicators of Microvascular and Macrovascular Complications in Type 2 Diabetes.

机构信息

Department of Internal Medicine, Istanbul Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey.

Istanbul Arnavutköy District Health Directorate, Ministry of Health, Istanbul, Turkey.

出版信息

Metab Syndr Relat Disord. 2024 Oct;22(8):619-625. doi: 10.1089/met.2024.0022. Epub 2024 Jun 5.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is more prevalent in patients with obesity, diabetes, and metabolic syndrome, which are risk factors for nonalcoholic steatohepatitis and liver fibrosis. NAFLD is related to cardiovascular outcomes in diabetes. We aimed to investigate the relationship between diabetic complications and NAFLD fibrosis score (NFS) and Fibrosis-4 score (FIB-4). Three hundred patients with type 2 diabetes mellitus (T2DM) were retrospectively evaluated according to NAFLD diagnosis on ultrasound in outpatient clinic. Risk of advanced fibrosis was estimated using FIB-4 and NFS. Diabetic complications of the patients were noted. Presence of diabetic retinopathy is related to FIB-4 ( = 0.001) and NFS ( < 0.001) scores. NFS score ( = 0.037), not FIB-4 ( = 0.517), is related to diabetic nephropathy. Among macrovascular complications, only coronary artery disease is related to NFS and FIB-4 scores ( = 0.037 and = 0.004, respectively). Although we cannot establish any association between fasting blood glucose, glycosylated hemoglobin (HbA1c) values and noninvasive liver fibrosis scores ( > 0.05), diabetes duration, and age positively correlated with the FIB-4 score ( = 0.033, = 0.001). In logistic regression analysis, NFS > 0.676 values are associated with increased rates of diabetic retinopathy, independent of age, sex, HbA1c, and duration diabetes (odds ratio: 1.155, = 0.030). FIB-4 has no relation with microvascular complications according to logistic regression analysis ( > 0.05 for all). Neither FIB-4 nor NFS has an effect on the presence of macrovascular complications ( > 0.05 for all). Our findings suggest that increase in NFS score is associated with the presence of diabetic retinopathy, independent of confounding factors. Further studies are needed on the applicability of noninvasive fibrosis scores in monitoring the presence of diabetic microvascular and macrovascular complications.

摘要

非酒精性脂肪性肝病(NAFLD)在肥胖、糖尿病和代谢综合征患者中更为常见,这些疾病是发生非酒精性脂肪性肝炎和肝纤维化的危险因素。NAFLD 与糖尿病患者的心血管结局相关。我们旨在研究糖尿病并发症与 NAFLD 纤维化评分(NFS)和纤维化-4 评分(FIB-4)之间的关系。

我们回顾性评估了 300 例在门诊接受超声检查诊断为 NAFLD 的 2 型糖尿病(T2DM)患者。使用 FIB-4 和 NFS 评估晚期纤维化的风险。记录患者的糖尿病并发症。

糖尿病视网膜病变与 FIB-4( = 0.001)和 NFS( < 0.001)评分相关。NFS 评分( = 0.037),而非 FIB-4( = 0.517)与糖尿病肾病相关。在大血管并发症中,只有冠心病与 NFS 和 FIB-4 评分相关(分别为 = 0.037 和 = 0.004)。

虽然我们不能建立空腹血糖、糖化血红蛋白(HbA1c)值与非侵入性肝纤维化评分之间的任何关联( > 0.05),但糖尿病病程和年龄与 FIB-4 评分呈正相关( = 0.033, = 0.001)。在逻辑回归分析中,NFS > 0.676 值与糖尿病视网膜病变的发生率增加相关,独立于年龄、性别、HbA1c 和糖尿病病程(比值比:1.155, = 0.030)。根据逻辑回归分析,FIB-4 与微血管并发症无关(均 > 0.05)。NFS 和 FIB-4 均对大血管并发症的发生无影响(均 > 0.05)。

我们的研究结果表明,NFS 评分的升高与糖尿病视网膜病变的发生有关,且不受混杂因素的影响。需要进一步研究非侵入性纤维化评分在监测糖尿病微血管和大血管并发症中的适用性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验